apraglutide: Clinical Trials

5 trials of apraglutide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 withdrawn. 5 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 4, Withdrawn 1
Phase 21Withdrawn 1

Follow apraglutide: new trials by email Literature Review of apraglutide trials Research Report on apraglutide

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Relative Bioavailability of a New Presentation of Apraglutide Versus the Reference Formulation
Apraglutide - Healthy Subjects
Phase 1CompletedVectivBio AG342023-05-232024-10-26
Evaluation of Apraglutide on Gastric Emptying
Apraglutide, Placebo, Acetaminophen - Healthy Subjects
Phase 1CompletedVectivBio AG422023-03-022024-10-24
A Phase 1 Open-Label Evaluation of the Pharmacokinetics and Safety of a Single Dose of Apraglutide in Subjects With Normal and Impaired Hepatic Function
Apraglutide - Hepatic Impairment
Phase 1CompletedVectivBio AG162023-01-302025-07-10
Study of Pharmacokinetics and Safety of Apraglutide in Participants With Normal and Impaired Kidney Function.
Apraglutide - Chronic Kidney Disease
Phase 1CompletedVectivBio AG162020-12-082024-10-26
Safety, Tolerability, PK/PD of FE 203799 in Adults With Lymphomas
FE 203799 - Lymphoma, Non-Hodgkin's, Adult, Lymphoma, Hodgkin's, Adult
Phase 1 / Phase 2WithdrawnGlyPharma Therapeutics2018-09-012024-10-24

Conditions studied

Hodgkin Disease (1)  ·  Lymphoma (1)  ·  Mucositis (1)  ·  Renal Insufficiency (1)  ·  Renal Insufficiency, Chronic (1)

Sponsors

VectivBio AG (4)  ·  GlyPharma Therapeutics (1)

Countries

Netherlands (2)  ·  Germany (1)  ·  Slovakia (1)  ·  United States (1)

Top investigators

Tomasz Masior (5)

Results publications

PMID 38465515